Clinical trial

Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin

NCT03804983

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-01-15

PhaseNA

Study timeline

Study start (actual)2019-01-15Date precision: day

Registry last updated2024-08-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetes Mellitusunresolved

Interventions

Hybrid Closed Loop (HCL)DEVICE

Control-IQ with MyTDIDEVICE

Sponsors & collaborators

University of Virginialead sponsor

Tandem Diabetes Care, Inc.collaborator

DexCom, Inc.collaborator

Mapped research locations

CharlottesvilleVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03804983 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.